Moderna's Covid-19 vaccine may be ready for use by December
MODERNA
$107.17
04:50 26/04/24
0.93%
$0.99
Moderna's Covid-19 vaccine candidate could be ready for use in December, the company's boss said.
AstraZeneca
11,930.00p
14:50 26/04/24
-0.80%
-96.00p
FTSE 100
8,131.78
14:50 26/04/24
n/a
n/a
FTSE 350
4,465.87
14:50 26/04/24
n/a
n/a
FTSE All-Share
4,419.29
14:50 26/04/24
n/a
n/a
Pfizer Inc.
$34.31
17:15 22/03/17
17.46%
$5.10
Pharmaceuticals & Biotechnology
22,664.47
14:49 26/04/24
-0.38%
-86.01
Speaking at The Wall Street Journal's annual Tech Live conference, the head of the biotechnology outfit, Stephane Bancel, said that if positive interim results from a large scale trial were available in November, then US government authorisation might arrive by the following month.
The firm is one of the front-runners in efforts to develop a vaccine.
If enough interim results took longer, then emergency use approval from the government might not occur until early in 2021.